Clinical Trial Update: 68Ga-P16-093 PET/CT Imaging in the Salivary Gland [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating 68Ga-P16-093 PET/CT imaging for primary Sjögren syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• 68Ga-P16-093 (P16-093 Ga-68 radiopharmaceutical)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Sjögren Syndrome | Phase 1, Phase 2 | Status: UNKNOWN